NIAID Emerging and Re-emerging Infectious Diseases NIAID Bioinformatics Resource Centers NIAID Structural Genomic Centers Center for Structural Genomics of Infectious Disease
Seattle Structural Genomics Center for Infectious Disease

BobuA.17750.a: 4-alpha-glucanotransferase (MalQ)

Target Characteristics

from organism: Borrelia burgdorferi B31
most recent status: expressed
center reference id: BobuA.17750.a
is community request: False
associated disease: Lyme disease
NIH risk group: 2
is select agent: False
NIH priority
pathogens category:
I

Ordering Clones & Proteins

If there are materials available for this target, they will be listed below. Materials can be ordered from SSGCID using the button in the "order material" column. Clicking the button will add the material to a virtual cart. You may order multiple materials at a time at no cost to you, as this contract is funded by NIAID. When you are ready to place your order, click the "Place Order" link which will appear in the top right corner of the page after you place your first item in your cart.

Clones*

CENTER
REFERENCE ID
DOMAIN/REGION
DESCRIPTION
INFO AA
START
AA
STOP
ORDER
MATERIAL
BobuA.17750.a.A1.GE32514 Full length( BobuA.17750.a ) 1 506 GE32514
* SSGCID clones represent un-induced expression constructs which have been verified by sequencing from vector primers. Clones may contain a tag, such as N-term 6xHis. Get sequence information using the button in the "info" column.

External Resources

Resource Reference ID
OrthoMCL: OG5_133321
PATRIC ID: fig|224326.49.peg.563
RefSeq: NP_212300.1
UniProt: O51188

Enzyme & Pathway Information

Pathway Pathway ID EC Number
glycogen degradation I GLYCOCAT-PWY 2.4.1.25
glycogen degradation III PWY-5767 2.4.1.25
starch degradation II PWY-6724 2.4.1.25
starch degradation V PWY-6737 2.4.1.25
sucrose biosynthesis II PWY-7238 2.4.1.25

Sequences

These sequences are the native gene sequence; sequences of constructs derived from these sequences may differ due to codon optimization or other protocols. To find the specific sequence of any material you may have ordered, click on the "more" button next to the name of that material.
AA Sequence
MKYKKTRINL NLKRKSGILL NISSLPSKYG IGDLGKGAYK FIDFLFASSQ SYWQMFAYSP IDFTRSPPYS IFSAFAGNVY YIDLEALDKF IDSDLSLLKE NETRYSDLKK ISFKDKFLKE AALNFINRAS ADEVRSFEKF KKKSSYWLLD FASFVAFKEY FFKESKNAFN VLFDRGILKR NEKDLFKLRN ILSKEIKVQE VLQYFFFSQF QALKRYANDK GIELIMNVPF FIAYDSADVW AYQKYFKLRF DASKDKIAGI SPDYFLEQEQ AWDSAAYSWN VLKKFKYEWW AKRIGVLRKY ADIIKIDHFR GFVSTWEVSA GESYAFNGLW VKSPGRDFFN FILNEIKDLK IWVEDFQNDL EDVSRLRDFF NFPGMKIMNL AFDFDSSNQN LPHNYIKNCI VYTGSGDNDT IREFINSLDD LHKKYIFDYL NTNENFVVWD MIRSAMGSVS DNVIVSMQDY INLGDKFSAN IPKSTLDNCI FRLLESDLDA TLSQNISFIT RLYGRA

NT Sequence
ATGAAATATA AAAAAACAAG GATTAATTTA AACTTAAAAA GAAAAAGTGG TATTTTGCTT AACATAAGCT CTTTACCATC TAAATATGGC ATTGGAGATT TAGGGAAAGG AGCTTATAAA TTTATAGATT TTTTGTTTGC ATCTTCTCAA AGTTATTGGC AAATGTTTGC TTATTCCCCT ATTGATTTTA CAAGATCTCC CCCTTATTCA ATTTTTTCGG CTTTTGCTGG CAATGTTTAT TATATTGATT TAGAAGCCCT TGACAAATTT ATAGATTCAG ATTTAAGTCT TTTAAAAGAA AATGAAACCA GGTATTCTGA TTTAAAAAAA ATAAGTTTTA AAGATAAATT TCTTAAAGAA GCCGCTTTAA ATTTTATTAA TAGAGCTTCG GCTGATGAGG TTAGAAGCTT TGAAAAATTT AAAAAAAAGT CTTCTTATTG GCTTTTAGAT TTTGCAAGTT TTGTTGCGTT TAAAGAATAT TTTTTTAAAG AGTCAAAGAA TGCTTTTAAT GTTCTTTTTG ATAGAGGAAT TCTTAAAAGA AATGAAAAAG ATTTATTTAA ATTGAGAAAT ATCCTTTCAA AAGAGATTAA AGTGCAAGAG GTATTGCAGT ATTTCTTTTT TTCACAGTTT CAAGCTTTAA AGCGCTATGC AAATGATAAG GGGATTGAGC TAATTATGAA CGTGCCTTTT TTTATAGCAT ATGACTCTGC TGATGTTTGG GCATACCAAA AATATTTTAA GCTAAGATTT GATGCAAGCA AAGATAAGAT TGCAGGAATT TCTCCAGATT ATTTTTTAGA ACAAGAGCAA GCTTGGGATA GTGCAGCTTA TAGCTGGAAT GTTTTAAAGA AATTTAAGTA TGAATGGTGG GCAAAAAGGA TTGGGGTTTT AAGAAAGTAT GCAGATATAA TTAAAATTGA TCATTTCAGA GGTTTTGTTT CTACTTGGGA AGTTAGTGCG GGCGAGTCTT ATGCTTTTAA TGGGTTGTGG GTAAAGTCGC CAGGACGAGA TTTTTTCAAT TTTATTTTAA ATGAAATTAA AGATTTAAAA ATTTGGGTTG AAGATTTTCA AAATGATCTT GAAGATGTTT CAAGACTAAG AGATTTTTTT AATTTTCCAG GAATGAAAAT AATGAATCTT GCCTTTGATT TTGATTCAAG CAATCAAAAT CTTCCTCATA ATTATATTAA AAATTGCATA GTTTACACAG GAAGTGGTGA TAATGATACA ATACGAGAGT TTATTAATTC TTTAGATGAT TTGCATAAAA AGTACATTTT TGATTATTTA AATACAAATG AAAATTTTGT TGTTTGGGAC ATGATAAGAA GTGCTATGGG TAGTGTTTCT GATAATGTGA TAGTGTCAAT GCAAGATTAT ATTAATTTAG GAGATAAATT TAGTGCAAAT ATCCCAAAAA GCACTTTAGA TAATTGTATT TTTAGATTAT TAGAAAGTGA TTTAGATGCT ACTTTGAGTC AAAATATAAG TTTTATTACA AGGCTTTATG GCAGGGCT

© 2022 Seattle Children's Research Institute. All rights reserved.